Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products.
OAKVILLE, ON, Nov. 3, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it will release its Q3 2020 financial results after the close on Thursday, November 12, 2020. The Company will hold a conference call on Friday, November 13, 2020 to discuss the results.
CONFERENCE CALL DETAILS
|
DATE: |
Friday, November 13, 2020 |
|
TIME: |
8:30 a.m ET |
|
DIAL-IN: |
(416) 764-8688 or (888) 390-0546 |
|
CONFERENCE ID: |
46246305 |
|
REPLAY DIAL-IN: |
1 (888) 390-0541 (Playback 246305 #) |
|
Expires November 20, 2020 |
|
|
Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1397006&tp_key=a8d3b9b5c2 |
|
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
